Attempts to make models for Alzheimer's disease

Neuroscience Research

Volumn 13, Issue 4, 1992, Pages 237-255

  Shiosaka, Sadao ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Alzheimer's disease; Animal model; Diphtheria toxin; Meynert's nucleus; Nerve growth factor

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; DIPHTHERIA TOXIN; ELECTROLYTE; GALANIN; NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; AMNESIA; ANIMAL MODEL; CELL CULTURE; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; DECORTICATION; DEGENERATION; DISEASE MODEL; FOREBRAIN; GENE TECHNOLOGY; IMMUNOCOMPETENT CELL; LEARNING; LEARNING DISORDER; MAGNOCELLULAR NUCLEUS; MEMORY; NERVE CELL; NEUROTOXICITY; NEUROTROPISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMAL; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; MEMORY; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; PARASYMPATHETIC NERVOUS SYSTEM; PROSENCEPHALON; SUPPORT, NON-U.S. GOV'T; VASOPRESSINS;

EID: 0026554104     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-0102(92)90037-D     Document Type: Review

References (128)

1. The effect of physostigmine and scopolamine on recognition memory in monkeys
2. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo
3. Memory facilitation with posttrial injection of oxotremoline and physostigmine in mice
4. The cholinergic hypothesis of geriatric memory dysfunction
5. Galanin-like immunoreactivity in Alzheimer's disease and Parkinson's disease dementia cerebral cortex
6. Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypothesis of dementia
7. Vasopressin analog (DDAVP) improves memory in human males
8. Regional pattern of degeneration in Alzheimer's disease, neuronal loss, and histopathological grading
9. Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist
10. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia
11. Cell biology of amyloid β-protein precursor
12. Cholinesterase inhibition in treatment of Alzheimer's dementia
13. Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine
14. Down syndrome, Alzheimer's disease and the trisomy 16 mouse
15. The use of excitatory amino acids as selective neurotoxin
16. Alzheimer's disease: a disorder of cortical cholinergic innervation
17. Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia?
18. Selective loss of central cholinergic neurons in Alzheimer's disease
19. Reduced somatostatine-like immunoreactivity in cerebral cortex form cases of Alzheimer disease and Alzheimer senile dementia
20. Physostigmine: improvement of long-term memory processes in normal humans
21. Immunohistochemical localization of β nerve growth factor receptors in the forebrain of the rat
22. Magnocellular nuclei of the basal forebrain project to neocortex, brain stem, and olfactory bulb. Review of some functional correlate
23. Human memory and the cholinergic system
24. Behavioral, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats
25. Transient expression of NGF-receptor-like immunoreactivity in postnatal rat brain and spinal cord
26. Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide
27. Mouse models for Down syndrome and Alzheimer's disease
28. Developmental and regional expression of β-nerve growth factor receptor mRNA in the chick and rat
29. Vasopressin but not oxytocin enhances cortical arousal: an integrative hypothesis on behavioral effects of neurohypophyseal hormones
30. Cholinergic mechanisms in learning memory and dementia a review of recent evidence
31. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies
32. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat
33. Neuropeptide changes in aging and Alzheimer's disease
34. A rapid radiochemical method for the determination of choline acetyltransferase
35. Effects of injected Alzheimer β-amyloid cores in rat brain
36. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
37. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease
38. Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease
39. Characterization and chromosomal localization of cDNA encoding brain amyloid of Alzheimer's disease
40. Expression of β amyloid protein precursor mRNAs: Recognition of novel alternatively spliced from and quantitation in Alzheimer's disease using PCR
41. Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis
42. The effect of chronic vs. acute injection of vasopressin on animal learning and memory
43. Segregation of a missence mutation in the amyloid precursor protein gene with familial Alzheimer's disease
44. Amyloid deposition as the central event in the aetiology of Alzheimer's disease
45. Regional decreases of cortical choline acetyltransferase after lesions of the septal area and in the area of nucleus magnocellularis
46. Nerve growth factor and cholinergic neurons of the mammalian brain
47. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments
48. High-affinity NGF binding requires co-expression of the trk proto-oncogene and the low-affinity NGF receptor
49. Centrally administered vasopressin antagonizes pentobarbital-induced narcosis and depression of hippocampal cholinergic activity
50. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenetic mice overexpressing a C-terminal fragment of human amyloid precursor protein
51. Specific cholinergic destruction in the basal magnocellular nucleus and impaired passive avoidance behavior of rodents
52. Alzheimer dementia and reduced nicotinamide adenine dinucleotide (NADH)-diaphorase activity in senile plaques and the basal forebrain
53. The role of NGF in sensory neuron in vivo
54. Evidence for a cholinergic projection to neocortex from neuron in basal forebrain
55. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
56. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): distribution, morphology, and colocalization with cholinergic enzymes
57. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation
58. Alzheimer plaques and tangles: advances on both fronts
59. An attempt to cause the selective loss of the cholinergic neurons in the basal forebrain of the rat: a new animal model of Alzheimer's disease
60. The nucleus basalis magnocellularis: The origin of a cholinergic projection to the neocortex of the rat
61. Neurochemical lesion models
62. Nerve growth factor
63. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch-type
64. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices
65. Lesion of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine action
66. Cerebral amyloidosis, aging and Alzheimer's disease: A contribution from studies on Down's syndrome
67. Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system
68. A galanin-like peptide coexists in putative cholinergic somata of the septum-basal forebrain complex and in acetylcholinesterase-containing fibers and varicosities within the hippocampus in the owl monkey (Aotus trivigatus)
69. Galanin-like immuno reactivity in cholinergic neurons of the septum-Basal forebrain complex projecting to the hippocampus of the rat
70. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6)
71. Characteristics of memory impairment following lesioning of basal forebrain and medial septal nucleus in rats
72. Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks
73. Studies on the content, synthesis and deposition of quinolic acid in physiology and pathology
74. Tau in PHF
75. Somatostatin in neurolytic plaques of Alzheimer's patient
76. The effect of vasopressin on memory in the healthy elderly
77. Developmental expression of the amyloid precursor protein, growth associated protein 43, and somatostatin in normal and trisomy 16 mice
78. Demonstration of retrogradely transported exogenous nerve growth factor in axons of sympathetic neurons
79. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
80. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
81. Localization of vasopressin binding sites in rat brain by in vitro autoradiography using a radioiodinated V1 receptor antagonist
82. Cholinergic dysfunction in Alzheimer disease: cause or effect?
83. Formation of β-amyloid protein deposits in brain of transgenic mice
84. Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer
85. Learning impairments following lesion of the basal nucleus of Meynert: modification by cholinergic drugs
86. Comparison of the effects of acute and chronic ibotenic and quisqualic acid nucleus basalis lesioning
87. Molecular cloning and characterization of cDNA encoding the cerebrovascular neuritic plaque amyloid peptides
88. Chromosome 21q21 sublocalization of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome
89. Location of neuronal tangles in somatostatin neurons in Alzheimer's disease
90. Receptor binding activities of biotinylated derivatives of β-nerve growth factor
91. Neuropeptides and dementia
92. Cholinergic neurons of the laterodorsal tegmental nucleus: efferent and afferent connections
93. Expression of NGF receptor in the developing and adult primate central nervous system
94. Nerve growth factor (NGF) in the rat CNS. Absence of specific retrograde transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra
95. Specific retrograde transport of nerve growth factor (NGF) from the neocortex to nucleus basalis in the rat
96. Studies on the expression of the β nerve growth factor (NGF) gene in the central nervous system: Levels and regional distribution of NGFmRNA suggests that NGF functions as a trophic factor for several distinct populations of neurons
97. A new animal model of Alzheimer's disease by selective destruction of the cholinergic neurons in the basal forebrain
98. Vasopressin impairs or enhances retention of learned submissive behavior in mice depending on the time of application
99. 125I-galanin binding sites in the rat central nervous system
100. Animal models of Alzheimer's disease: experimental cholinergic denervation
101. Degeneration of cholinergic neurons in the basal nucleus following kainic or N-methyl-d-aspartic acid application to the cerebral cortex in the rat
102. Experimental studies on the induction and prevention of retrograde degeneration of basal forebrain cholinergic neurons
103. Nerve growth factor receptors in the central nervous system
104. The genetic defect causing familial Alzheimer's disease maps on chromosome 21
105. Retrograde axonal transport of nerve growth factor: specificity and biological importance
106. Basic fibroblast growth factor in Alzheimer's disease
107. Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze
108. Cholinergic receptor blockade impairs spatial localization by use of distal cue in the rat
109. Amyloid β-protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus
110. Galanin — a novel biologically active peptide from porcine intestine
111. Memory enhancement with oral physostigmine in Alzheimer's disease
112. Neurotrophic action of Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons
113. Familial hypothalamic diabetes insipidus in rat (Brattleboro strain)
114. Amyloid β-protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch)
115. Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert
116. AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat
117. Effects of vasopressin on human memory
118. Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rat
119. Basal forebrain lesion and memory: Alteration in neurotensin, not acetylcholine, may cause amnesia
120. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain
121. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis
122. Neocortical neurons in elderly people
123. Memory deficit in rats with hereditary diabetes insipidus
124. Age-related changes in Down syndrome brain and the cellular pathology of Alzheimer disease
125. The role of vasopressin in memory processes
126. Deposit of amyloid β-protein in the central nervous system of transgenic mice
127. Molecular dissection of Alzheimer pathology
128. Dysdifferentiation of structurally plastic neurons initiates the pathologic cascade of Alzheimer's disease: toward a unifying hypothesis